Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.

Jones JL, Scheidt DJ, Kaushal RS, Carroll CA.

J Med Econ. 2013;16(2):213-20. doi: 10.3111/13696998.2012.744316. Epub 2012 Nov 8.

PMID:
23098539
2.

Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis.

Simpson D, Noble S, Perry C.

BioDrugs. 2003;17(3):207-10. Review.

PMID:
12749757
3.

Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.

Johnson KP.

Expert Rev Neurother. 2012 Apr;12(4):371-84. doi: 10.1586/ern.12.25. Review.

PMID:
22449210
4.

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.

Simpson D, Noble S, Perry C.

CNS Drugs. 2002;16(12):825-50. Review.

PMID:
12421116
5.

Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis.

Qizilbash N, Mendez I, Sanchez-de la Rosa R.

Clin Ther. 2012 Jan;34(1):159-176.e5. doi: 10.1016/j.clinthera.2011.12.006. Review.

PMID:
22284996
6.

Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data.

Caon C, Saunders C, Smrtka J, Baxter N, Shoemaker J.

J Neurosci Nurs. 2010 Oct;42(5 Suppl):S5-9. Review.

PMID:
21049828
7.

Glatiramer acetate for multiple sclerosis.

[No authors listed]

Drug Ther Bull. 2001 Jun;39(6):41-3. Review.

PMID:
11432030
8.

Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.

Weber MS, Hohlfeld R, Zamvil SS.

Neurotherapeutics. 2007 Oct;4(4):647-53. Review.

PMID:
17920545
9.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
10.

Glatiramer acetate for the treatment of multiple sclerosis.

Wolinsky JS.

Expert Opin Pharmacother. 2004 Apr;5(4):875-91. Review.

PMID:
15102570
11.

Considerations in the treatment of relapsing-remitting multiple sclerosis.

Calabresi PA.

Neurology. 2002 Apr 23;58(8 Suppl 4):S10-22. Review.

PMID:
11971122

Supplemental Content

Support Center